Abbott makes deal with FDA, says infant formula plant could reopen within weeks

The FDA and Abbott Nutrition released details of a deal this week that could lead to the reopening of an infant formula plant that was closed earlier this year amid a recall related to bacterial contamination.
The FDA also announced other updates and guidance pertaining to the ongoing infant formula shortage in the United States.
FDA Commissioner Robert M. Califf, MD, said the agency was “leaving no stone unturned to further increase the availability of infant formula.”
“We are doing everything in our power as part of the all-of-government efforts to ensure there’s

The FDA and Abbott Nutrition released details of a deal this week that could lead to the reopening of an infant formula plant that was closed earlier this year amid a recall related to bacterial contamination.
The FDA also announced other updates and guidance pertaining to the ongoing infant formula shortage in the United States.
FDA Commissioner Robert M. Califf, MD, said the agency was “leaving no stone unturned to further increase the availability of infant formula.”
“We are doing everything in our power as part of the all-of-government efforts to ensure there’s